Taken together, these results suggested that inhibiting lncRNA Dlx6-os1 expression in kidney podocytes could represent an effective approach to alleviate the podocyte injury, inflammation, and albuminuria associated with DN. The gene discussed is FRZB; the disease is liver dysplastic nodule.